SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2002

LIPID SCIENCES, INC.

(Exact name of registrant as specified in its charter)

Delaware	0-497	43-0433090
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S Employer Identification No.)

7068 Koll Center Parkway, Suite 401, Pleasanton, California	94566
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:   (925) 249-4000

TABLE OF CONTENTS

	Item 7. Financial Statements and Exhibits
	Item 9. Regulation FD Disclosure
SIGNATURE
EXHIBIT INDEX
EX-99.1

Item 7. Financial Statements and Exhibits

         (c)  Exhibits

Exhibit	Description
99.1	Letter to Stockholders from the Chairman of the Board of Lipid Sciences, Inc.

Item 9. Regulation FD Disclosure

         On November 6, 2002, Lipid Sciences, Inc., a Delaware corporation, forwarded to its stockholders a letter from the Chairman of the Board. The letter is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lipid Sciences, Inc.
Date:  November 6, 2002	By:	/s/ Barry Michaels
	Name: Title:	Barry Michaels Chief Financial Officer

EXHIBIT INDEX

Exhibit	Description
99.1	Letter to Stockholders from the Chairman of the Board of Lipid Sciences, Inc.